Nutrien slides 6.7% as investors digest Q1 results and unchanged full-year outlook

Nutrien Ltd. (NTR) is down 6.7% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears tied to an earnings-day reset in expectations: while Nutrien posted improved first-quarter performance and highlighted strong potash volumes, it kept its full-year guidance unchanged. Investors may have focused on cost pressures (notably higher sulfur costs affecting phosphates) and uncertainty around global fertilizer and energy trade flows, which can complicate margin and cash-flow visibility.

Details:

The company reported first-quarter net earnings of $139 million ($0.27 per share) and adjusted EBITDA of $1.11 billion, citing stronger Nitrogen and Retail performance and record potash sales volumes.

Management reaffirmed full-year 2026 guidance ranges rather than raising them, despite discussing firm-to-tight fertilizer market conditions in 2026.

Phosphates profitability was pressured in the quarter, with higher sulfur input costs weighing on segment results even as sales rose.

The company reiterated ongoing portfolio actions, including strategic reviews involving the phosphates business and certain non-core assets, which can add headline risk while outcomes and timing remain uncertain.

Sources:

Nutrien (press release), Reuters, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$NTR Hedge Fund Activity

We have seen 324 institutional investors add shares of $NTR stock to their portfolio, and 299 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP added 13,313,817 shares (+440.2%) to their portfolio in Q4 2025, for an estimated $821,728,785
ARGA INVESTMENT MANAGEMENT, LP removed 5,265,902 shares (-99.2%) from their portfolio in Q1 2026, for an estimated $396,785,715
ROYAL BANK OF CANADA removed 3,761,503 shares (-10.8%) from their portfolio in Q4 2025, for an estimated $232,159,965
FMR LLC removed 3,719,002 shares (-23.8%) from their portfolio in Q4 2025, for an estimated $229,536,803
SILCHESTER INTERNATIONAL INVESTORS LLP removed 2,746,328 shares (-67.7%) from their portfolio in Q1 2026, for an estimated $206,935,814
CITADEL ADVISORS LLC removed 2,582,687 shares (-93.8%) from their portfolio in Q4 2025, for an estimated $159,403,441
TORONTO DOMINION BANK added 2,140,598 shares (+72.0%) to their portfolio in Q4 2025, for an estimated $132,117,708

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$NTR Analyst Ratings

Wall Street analysts have issued reports on $NTR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Morgan Stanley issued a "Overweight" rating on 01/14/2026

To track analyst ratings and price targets for $NTR, check out Quiver Quantitative's $NTR forecast page.

$NTR Price Targets

Multiple analysts have issued price targets for $NTR recently. We have seen 17 analysts offer price targets for $NTR in the last 6 months, with a median target of $80.0.

Here are some recent targets:

Michael Tupholme from TD Cowen set a target price of $86.0 on 05/06/2026
Hamir Patel from CIBC set a target price of $88.0 on 04/30/2026
Benjamin Theurer from Barclays set a target price of $85.0 on 04/27/2026
Kristen Owen from Oppenheimer set a target price of $80.0 on 04/22/2026
Ben Isaacson from Scotiabank set a target price of $75.0 on 04/20/2026
Vincent Sinisi from Morgan Stanley set a target price of $93.0 on 04/08/2026
Lucas Beaumont from UBS set a target price of $67.0 on 03/26/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.